Subscribe to Newsletter

May 2020 Issue of The Medicine Maker

Gareth Jenkins, CSO at Arcinova, UK, outlines the steps pharma is taking to move towards a data-driven future in this month’s cover feature. In Profession, Robert Dudley, Chairman, CEO, and President of Clarus Therapeutics, discusses the lessons he has learned in a career dedicated to men’s health. And experts from across the industry take time to share their thoughts on how the COVID-19 pandemic is shaping their professional lives in our new Pandemic Diaries series.

Register to download
Register here to download any issue of The Medicine Maker for FREE.
Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Articles featured in this issue

Business & Regulation Trends & Forecasts

The Counterfeit COVID-19 Crisis

| Stephanie Vine

How fakers are taking advantage of the pandemic.

Discovery & Development Drug Discovery

Stronger Together

| Maryam Mahdi

A repurposed drug could help improve immunotherapy response rates.

Business & Regulation Business Practice

COVID-19 in Brief

| Maryam Mahdi

What’s new in business?

Manufacture Bioprocessing - Upstream & Downstream

Editing for Purity

| Stephanie Vine

Secretome engineering eliminates unwanted proteins in CHO-based bioprocessing.

Discovery & Development Drug Discovery

Better Use Case

| Maryam Mahdi

Researchers are investigating the therapeutic value of immunotherapies for treating infectious diseases.

Discovery & Development Drug Discovery

Alleviating the Pressure

| Maryam Mahdi

A gene therapy could help prevent the symptoms of glaucoma.

Manufacture Drug Discovery

Let There Be Light

Using green light, a titanium catalyst could be a non-hazardous alternative to commonly used metal-based catalysts.

Manufacture Technology and Equipment

Winning Innovation

| Stephanie Vine

Announcing the grand winner of The Medicine Maker 2019 Innovation Awards.

Discovery & Development Drug Discovery

Back to Immunity

| Stephanie Vine

Can we reverse the effect of the ageing process on the immune system?

Discovery & Development Drug Discovery

Tracking the Pandemic

| Maryam Mahdi

A clinical trial tracker aims to encourage international collaboration on COVID-19 drug development.

Manufacture Vaccines

The Pandemic Diaries

| Mike Grippo, Andy Lane, Adrian Wildfire

We asked medicine makers around the world to tell us how their professional and personal lives have changed during the ongoing COVID-19 crisis.

Manufacture Advanced Medicine

Viral Vectors in Vogue

| Arvind Srivastava

We must collaborate to address stability challenges in viral vector manufacturing.

Manufacture Contract Manufacturing Services

Revving Up for the Revolution: Industry 4.0

| Gareth Jenkins

We’re moving towards a data-driven future of enhanced manufacturing. And we must lay the foundations today.

Manufacture Process Control

Room for Optimization

We speak with Richard Bourne about his work on pharmaceutical processes.

Manufacture Formulation

Navigating Technology Transfer for LNP Formulations

| Larry Beiter

Technology transfer can be a challenge with any drug product. Even greater vigilance is needed with more complex formulations, like LNP-based drugs.

Discovery & Development Drug Delivery

Breathing New Life into Existing Drugs

| Geraldine Venthoye

Inhaled administration has the potential to bring benefits to patients – and commercial success to businesses – across a number of therapeutic spaces.

Business & Regulation Business Practice

Devoted to Men’s Health: Lessons Learned with Robert Dudley

| Robert Dudley

Robert Dudley reveals his lessons learned and shares how he has tackled the challenges of launching the first oral TRT softgel approved by the FDA.

Business & Regulation Advanced Medicine

Rewriting the Rulebook

| James Strachan

Sitting Down With… Frédéric Triebel, Co-Founder, Chief Scientific Officer, and Chief Medical Officer of Immutep, France.

Other issues of 2020